Published in Neurosurgery on April 01, 2013
Open ulnar nerve decompression using small incision and alternate positioning. Neurosurgery (2014) 1.07
Endoscopic Versus Open Cubital Tunnel Release: A Systematic Review and Meta-Analysis. Hand (N Y) (2016) 0.75
Feasibility and limitations of endoscopy in Guyon's canal. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
In reply: Open ulnar nerve decompression using small incision and alternate positioning. Neurosurgery (2014) 0.75
Trends in Open and Endoscopic Cubital Tunnel Release in the Medicare Patient Population. Hand (N Y) (2016) 0.75
Long-term survival with glioblastoma multiforme. Brain (2007) 4.51
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol (2009) 3.65
Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol (2011) 3.01
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol (2010) 2.71
Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow. Neurosurgery (2003) 2.66
Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. J Neurosurg (2005) 2.42
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res (2011) 2.36
A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics (2009) 2.21
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol (2003) 2.14
Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol (2008) 2.07
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology (2013) 1.98
Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. J Neurosurg (2011) 1.84
Rapid closure technique in decompressive craniectomy. J Neurosurg (2010) 1.69
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer (2012) 1.67
Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke (2006) 1.62
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer (2011) 1.61
Risk of shunt-dependent hydrocephalus after occlusion of ruptured intracranial aneurysms by surgical clipping or endovascular coiling: a single-institution series and meta-analysis. Neurosurgery (2007) 1.57
Cranioplasty after decompressive craniectomy: the effect of timing on postoperative complications. J Neurotrauma (2012) 1.54
The Impact of Tracheostomy Timing on Clinical Outcome and Adverse Events in Poor-Grade Subarachnoid Hemorrhage. Crit Care Med (2015) 1.53
The influence of barometric pressure changes and standard meteorological variables on the occurrence and clinical features of subarachnoid hemorrhage. Surg Neurol (2007) 1.53
Oculomotor nerve palsy by posterior communicating artery aneurysms: influence of surgical strategy on recovery. J Neurosurg (2012) 1.48
Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery (2003) 1.42
Effect of apolipoprotein E genotype on the outcome after anterior cervical decompression and fusion in patients with cervical spondylotic myelopathy. J Neurosurg Spine (2009) 1.42
The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res (2010) 1.41
Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting. J Neurol Sci (2013) 1.40
Frequency, risk of hemorrhage and treatment considerations for cerebral arteriovenous malformations with associated aneurysms. Acta Neurochir (Wien) (2014) 1.39
Laser surface scanning for patient registration in intracranial image-guided surgery. Neurosurgery (2002) 1.38
Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep (2005) 1.37
The application of rapid prototyping techniques in cranial reconstruction and preoperative planning in neurosurgery. J Craniofac Surg (2003) 1.32
Size and location of ruptured and unruptured intracranial aneurysms measured by 3-dimensional rotational angiography. Surg Neurol (2006) 1.32
Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol (2006) 1.26
CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis (2007) 1.25
Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol (2010) 1.22
The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells (2007) 1.21
Ventriculoperitoneal shunt migration into the pulmonary artery. Acta Neurochir (Wien) (2009) 1.19
Different molecular patterns in glioblastoma multiforme subtypes upon recurrence. J Neurooncol (2009) 1.17
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res (2013) 1.17
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol (2015) 1.16
Ultra-long-term outcome of surgically treated far-lateral, extraforaminal lumbar disc herniations: a single-center series. Eur Spine J (2011) 1.14
Metastasis and angiogenesis. Cancer Treat Res (2004) 1.11
Bone flap resorption: risk factors for the development of a long-term complication following cranioplasty after decompressive craniectomy. J Neurotrauma (2013) 1.11
Assessment of flow in perforating arteries during intracranial aneurysm surgery using intraoperative near-infrared indocyanine green videoangiography. Neurosurgery (2007) 1.10
Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev (2006) 1.09
Primary meningeal osteosarcoma: case report and review of the literature. Neurosurgery (2002) 1.09
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme. J Neurooncol (2006) 1.08
Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg (2004) 1.07
Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J (2003) 1.07
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke (2002) 1.06
Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg (2005) 1.05
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol (2012) 1.04
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Pharmacol Ther (2013) 1.04
Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. J Neurooncol (2007) 1.04
Influence of surgical or endovascular treatment on visual symptoms caused by intracranial aneurysms: single-center series and systematic review. J Neurosurg (2011) 1.04
Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci (2003) 1.04
Benefit of tumor resection for recurrent glioblastoma. J Neurooncol (2014) 1.03
Navigated transcranial magnetic stimulation and functional magnetic resonance imaging: advanced adjuncts in preoperative planning for central region tumors. Neurosurgery (2011) 1.03
Intraoperative risk of seizures associated with transient direct cortical stimulation in patients with symptomatic epilepsy. J Clin Neurophysiol (2007) 1.03
Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway. Clin Cancer Res (2010) 1.02
STAT3 silencing inhibits glioma single cell infiltration and tumor growth. Neuro Oncol (2013) 1.02
Raman spectroscopic imaging for in vivo detection of cerebral brain metastases. Anal Bioanal Chem (2010) 1.01
The role of near-infrared angiography in the assessment of post-operative venous congestion in random pattern, pedicled island and free flaps. Br J Plast Surg (2005) 1.01
Tumor evasion from T cell surveillance. J Biomed Biotechnol (2011) 1.01
Simple and viable in vitro perfusion model for training microvascular anastomoses. Microsurgery (2004) 1.01
Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. FEBS J (2008) 1.01
Knockdown of TFPI-2 promotes migration and invasion of glioma cells. Neurosci Lett (2011) 1.01
The clinico-anatomic explanation for tibial intraneural ganglion cysts arising from the superior tibiofibular joint. Skeletal Radiol (2006) 1.00
Cerebellar hemorrhage after supratentorial craniotomy. Surg Neurol (2002) 1.00
Analysis of human brain tissue, brain tumors and tumor cells by infrared spectroscopic mapping. Analyst (2004) 0.99
Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group. Stroke (2014) 0.99
Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery (2006) 0.99
Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors. Analyst (2005) 0.99
Foramen magnum meningiomas: clinical outcome after microsurgical resection via a posterolateral suboccipital retrocondylar approach. Neurosurgery (2006) 0.99
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro Oncol (2011) 0.99
Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme. Oncology (2004) 0.99
Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke (2007) 0.98
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. Mol Cancer (2011) 0.98
Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol Ther (2010) 0.98
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer (2010) 0.98
Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage. Neuroradiology (2007) 0.98
Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65-94 years. Acta Neurochir (Wien) (2012) 0.97
Autologous bone flap cranioplasty following decompressive craniectomy is combined with a high complication rate in pediatric traumatic brain injury patients. Acta Neurochir (Wien) (2014) 0.97
Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development. Neurosurgery (2003) 0.97
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. J Neurooncol (2008) 0.97
Treatment related morbidity of unruptured intracranial aneurysms: results of a prospective single centre series with an interdisciplinary approach over a 6 year period (1999-2005). J Neurol Neurosurg Psychiatry (2007) 0.97
Decompressive craniectomy in subarachnoid hemorrhage. Neurosurg Focus (2009) 0.96
Functional magnetic resonance imaging-integrated neuronavigation: correlation between lesion-to-motor cortex distance and outcome. Neurosurgery (2004) 0.95
Assessment of neuropsychological parameters and quality of life to evaluate outcome in patients with surgically treated supratentorial meningiomas. Neurosurgery (2009) 0.95
S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res (2004) 0.95
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Int J Cancer (2014) 0.95
Posterior communicating artery aneurysm-related oculomotor nerve palsy: influence of surgical and endovascular treatment on recovery: single-center series and systematic review. Neurosurgery (2011) 0.95
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. Neuro Oncol (2010) 0.95
Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae. Neurol Res (2003) 0.95
Traumatic epidural hematomas in children and adolescents: outcome analysis in 39 consecutive unselected cases. Pediatr Emerg Care (2009) 0.94
Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. J Natl Cancer Inst (2011) 0.94